FIL Limited Form 8.3 - Abbvie Inc (3149M)
07 Mai 2020 - 3:15PM
UK Regulatory
TIDM0Y7T
RNS Number : 3149M
FIL Limited
07 May 2020
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing FMR LLC and/or one or more
(Note 1) of its direct or indirect
subsidiaries
And
FIL Limited and/or one
or more of its direct and
indirect subsidiaries
Company dealt in ABBVIE INC
==========================
Class of relevant security ORDINARY SHARES
to which the dealings
being disclosed relate
(Note 2)
==========================
Date of dealing 06-May-2020
==========================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
========== ====== =========== ======
(1) Relevant securities 32,465,868 2.19%
================== ===================
(2) Derivatives (other
than options)
================== ===================
(3) Options and agreements
to purchase/sell
================== ===================
Total 32,465,868 2.19%
================== ===================
THE ABOVE INCLUDES A TRANSFER IN OF 495 ORDINARY SHARES
(b) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
========= ====== =========== ======
(1) Relevant securities
=================== =====================
(2) Derivatives (other
than options)
=================== =====================
(3) Options and agreements
to purchase/sell
=================== =====================
Total
=================== =====================
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/Sale Number of relevant securities Price per unit (Note 5)
Sale 2,039 86.76 USD/Share
------------------------------ ------------------------
Sale 1,900 86.84 USD/Share
------------------------------ ------------------------
Sale 3,150 86.86 USD/Share
------------------------------ ------------------------
Sale 17,511 86.91 USD/Share
------------------------------ ------------------------
Sale 6,500 86.92 USD/Share
------------------------------ ------------------------
Sale 11,000 89.96 USD/Share
------------------------------ ------------------------
Sale 3,011 87.02 USD/Share
------------------------------ ------------------------
Purchase 218,500 87.12 USD/Share
------------------------------ ------------------------
Sale 11,116 87.19 USD/Share
------------------------------ ------------------------
Sale 5,000 87.24 USD/Share
------------------------------ ------------------------
Sale 6,517 87.25 USD/Share
------------------------------ ------------------------
Sale 14,900 87.27 USD/Share
------------------------------ ------------------------
Sale 3,600 87.43 USD/Share
------------------------------ ------------------------
Sale 23,456 87.57 USD/Share
------------------------------ ------------------------
Sale 300 87.98 USD/Share
------------------------------ ------------------------
Sale 900 88.11 USD/Share
------------------------------ ------------------------
Purchase 11 86.94 USD/Share
------------------------------ ------------------------
Purchase 2,195 86.96 USD/Share
------------------------------ ------------------------
Sale 56 86.54 USD/Share
------------------------------ ------------------------
Sale 13,842 86.73 USD/Share
------------------------------ ------------------------
Sale 1 86.13 USD/Share
------------------------------ ------------------------
Sale 1 86.17 USD/Share
------------------------------ ------------------------
Sale 1 86.22 USD/Share
------------------------------ ------------------------
Sale 2 86.23 USD/Share
------------------------------ ------------------------
Sale 1 86.57 USD/Share
------------------------------ ------------------------
Sale 1 86.90 USD/Share
------------------------------ ------------------------
Sale 1 86.97 USD/Share
------------------------------ ------------------------
Sale 1 87.03 USD/Share
------------------------------ ------------------------
Sale 1 87.04 USD/Share
------------------------------ ------------------------
Sale 2 87.11 USD/Share
------------------------------ ------------------------
Sale 1 87.24 USD/Share
------------------------------ ------------------------
Sale 1 87.45 USD/Share
------------------------------ ------------------------
Sale 2 85.67 USD/Share
------------------------------ ------------------------
(b) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 6) securities unit
e.g. CFD (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(d) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and
any other person relating to the voting rights of any relevant
securities under any option referred to
on this form or relating to the voting rights or future
acquisition or disposal of any relevant securities to
which any derivative referred to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 07-May-2020
Contact name Paul Clark
================
Telephone number 00353 1 223 1447
================
If a connected EFM, name
of offeree/offeror with
which connected
================
If a connected EFM, state
nature of connection (Note
10)
================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ISEKKOBDNBKDNPK
(END) Dow Jones Newswires
May 07, 2020 09:15 ET (13:15 GMT)
Allergan (LSE:0Y7T)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Allergan (LSE:0Y7T)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
